BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9754466)

  • 1. Peritoneal clearance and peritoneal transfer of oxalic acid, vitamin C, and vitamin B6 during continuous ambulatory peritoneal dialysis.
    Mydlík M; Derzsiová K; Svác J; Dlhopolcek P; Zemberová E
    Artif Organs; 1998 Sep; 22(9):784-8. PubMed ID: 9754466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal replacement therapy and secondary hyperoxalemia in chronic renal failure.
    Mydlík M; Derzsiová K
    Kidney Int Suppl; 2001 Feb; 78():S304-7. PubMed ID: 11169031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxalic Acid as a uremic toxin.
    Mydlík M; Derzsiová K
    J Ren Nutr; 2008 Jan; 18(1):33-9. PubMed ID: 18089441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma concentration and peritoneal clearance of oxalate in patients on continuous ambulatory peritoneal dialysis (CAPD).
    Yamauchi A; Fujii M; Shirai D; Mikami H; Okada A; Imai E; Ando A; Orita Y; Kamada T
    Clin Nephrol; 1986 Apr; 25(4):181-5. PubMed ID: 3698351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamins and continuous ambulatory peritoneal dialysis (CAPD).
    Mydlík M; Derzsiová K; Válek A; Szabó T; Dandár V; Takác M
    Int Urol Nephrol; 1985; 17(3):281-6. PubMed ID: 4086241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of furosemide on urinary excretion of oxalic acid, vitamin C and vitamin B6 in chronic kidney failure].
    Mydlík M; Derzsiová K; Zemberová E; Rajnic A
    Vnitr Lek; 1998 Mar; 44(3):127-31. PubMed ID: 9820088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of vitamin B6 and its requirement in chronic renal failure.
    Mydlík M; Derzsiová K; Zemberová E
    Kidney Int Suppl; 1997 Nov; 62():S56-9. PubMed ID: 9350682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major factors modulating the serum oxalic acid level in hemodialysis patients.
    Ogawa Y; Machida N; Jahana M; Gakiya M; Chinen Y; Oda M; Morozumi M; Sugaya K
    Front Biosci; 2004 Sep; 9():2901-8. PubMed ID: 15353324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin nutrition in patients on continuous ambulatory peritoneal dialysis (CAPD).
    Blumberg A; Hanck A; Sander G
    Clin Nephrol; 1983 Nov; 20(5):244-50. PubMed ID: 6652978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
    Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B
    Nephron; 1996; 72(2):135-44. PubMed ID: 8684516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Water-soluble vitamin levels in patients undergoing high-flux hemodialysis and receiving long-term oral postdialysis vitamin supplementation.
    Descombes E; Boulat O; Perriard F; Fellay G
    Artif Organs; 2000 Oct; 24(10):773-8. PubMed ID: 11091166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin B6 and oxalic acid in clinical nephrology.
    Mydlík M; Derzsiová K
    J Ren Nutr; 2010 Sep; 20(5 Suppl):S95-102. PubMed ID: 20797580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ascorbic acid supplements in patients receiving chronic peritoneal dialysis.
    Shah GM; Ross EA; Sabo A; Pichon M; Bhagavan H; Reynolds RD
    Am J Kidney Dis; 1991 Jul; 18(1):84-90. PubMed ID: 2063860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of water and sodium diuresis and furosemide on urinary excretion of vitamin B(6), oxalic acid and vitamin C in chronic renal failure.
    Mydlík M; Derzsiová K; Zemberová E
    Miner Electrolyte Metab; 1999; 25(4-6):352-6. PubMed ID: 10681666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum oxalate in chronic renal failure.
    Borland WW; Payton CD; Simpson K; Macdougall AI
    Nephron; 1987; 45(2):119-21. PubMed ID: 3561621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of vitamin B6 administration on elevated plasma oxalic acid levels in haemodialysed patients.
    Balcke P; Schmidt P; Zazgornik J; Kopsa H; Deutsch E
    Eur J Clin Invest; 1982 Dec; 12(6):481-3. PubMed ID: 6818036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oxalic acid--important uremic toxin].
    Mydlík M; Derzsiová K
    Vnitr Lek; 2010 Jul; 56(7):695-701. PubMed ID: 20842915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma oxalate levels rise in hemodialysis patients despite increased oxalate removal.
    Costello JF; Sadovnic MJ; Cottington EM
    J Am Soc Nephrol; 1991 Jun; 1(12):1289-98. PubMed ID: 1912391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin B6 requirements of patients on chronic peritoneal dialysis.
    Ross EA; Shah GM; Reynolds RD; Sabo A; Pichon M
    Kidney Int; 1989 Oct; 36(4):702-6. PubMed ID: 2811067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oxalic acid metabolism in chronic renal failure].
    Balcke P
    Wien Klin Wochenschr Suppl; 1985; 160():1-15. PubMed ID: 3859955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.